These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 30199579)

  • 1. HBV seroprevalence after 25 years of universal mass vaccination and management of non-responders to the anti-Hepatitis B vaccine: An Italian study among medical students.
    Bianchi FP; Gallone MS; Gallone MF; Larocca AMV; Vimercati L; Quarto M; Tafuri S
    J Viral Hepat; 2019 Jan; 26(1):136-144. PubMed ID: 30199579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Persistence of protective anti-HBs antibody levels and anamnestic response to HBV booster vaccination: A cross-sectional study among healthcare students 20 years following the universal immunization campaign in Italy.
    Dini G; Toletone A; Barberis I; Debarbieri N; Massa E; Paganino C; Bersi F; Montecucco A; Alicino C; Durando P
    Hum Vaccin Immunother; 2017 Feb; 13(2):440-444. PubMed ID: 27925503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is hepatitis B vaccination performed at infant and adolescent age able to provide long-term immunological memory? An observational study on healthcare students and workers in Florence, Italy.
    Bini C; Grazzini M; Chellini M; Mucci N; Arcangeli G; Tiscione E; Bonanni P
    Hum Vaccin Immunother; 2018 Feb; 14(2):450-455. PubMed ID: 29106317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acquisition rate of antibody to hepatitis B surface antigen among medical and dental students in Japan after three-dose hepatitis B vaccination.
    Nagashima S; Yamamoto C; Ko K; Chuon C; Sugiyama A; Ohisa M; Akita T; Katayama K; Yoshihara M; Tanaka J
    Vaccine; 2019 Jan; 37(1):145-151. PubMed ID: 30449632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Persistence of Immunity for Hepatitis B Virus among Heathcare Workers and Italian Medical Students 20 Years after Vaccination.
    Coppeta L; Pompei A; Balbi O; Zordo LM; Mormone F; Policardo S; Lieto P; Pietroiusti A; Magrini A
    Int J Environ Res Public Health; 2019 Apr; 16(9):. PubMed ID: 31035698
    [No Abstract]   [Full Text] [Related]  

  • 6. Persistence of hepatitis B surface antibody and immune memory to hepatitis B vaccine among medical college students in Madinah.
    Mahallawi W
    Ann Saudi Med; 2018; 38(6):413-419. PubMed ID: 30531175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Waning immunity and booster responses in nursing and medical technology students who had received plasma-derived or recombinant hepatitis B vaccine during infancy.
    Lin CC; Yang CY; Shih CT; Chen BH; Huang YL
    Am J Infect Control; 2011 Jun; 39(5):408-414. PubMed ID: 21255876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Significance and anamnestic response in isolated hepatitis B core antibody-positive individuals 18 years after neonatal hepatitis B virus vaccination in Taiwan.
    Su FH; Bai CH; Chu FY; Lin YS; Su CT; Yeh CC
    Vaccine; 2012 Jun; 30(27):4034-9. PubMed ID: 22531558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implementation of hepatitis B vaccine in high-risk young adults with waning immunity.
    Posuwan N; Vorayingyong A; Jaroonvanichkul V; Wasitthankasem R; Wanlapakorn N; Vongpunsawad S; Poovorawan Y
    PLoS One; 2018; 13(8):e0202637. PubMed ID: 30125298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive factors for anti-HBs status after 1 booster dose of hepatitis B vaccine.
    Lu IC; Jean MC; Lin CW; Chen WH; Perng DS; Lin CW; Chuang HY
    Medicine (Baltimore); 2016 Sep; 95(39):e5023. PubMed ID: 27684874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Administering an additional hepatitis B vaccination dose after 18 years maintains adequate long-term protection levels in healthcare workers.
    Hess L; Riesenberg K; Rolston KVI; Nesher L
    Infect Dis (Lond); 2020 May; 52(5):330-335. PubMed ID: 31983251
    [No Abstract]   [Full Text] [Related]  

  • 12. Long-term immunogenicity of hepatitis B vaccination and policy for booster: an Italian multicentre study.
    Zanetti AR; Mariano A; Romanò L; D'Amelio R; Chironna M; Coppola RC; Cuccia M; Mangione R; Marrone F; Negrone FS; Parlato A; Zamparo E; Zotti C; Stroffolini T; Mele A;
    Lancet; 2005 Oct 15-21; 366(9494):1379-84. PubMed ID: 16226616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intradermal vaccination of adults with three low doses (2 micrograms) of recombinant hepatitis B vaccine. II. Persistence of immunity and induction of immunologic memory.
    Elisbão Mdo C; Baldy JL; Bonametti AM; Reiche EM; Morimoto HK; Pontello R; Matsuo T; Ferelle A; Neves J
    Mem Inst Oswaldo Cruz; 2003 Dec; 98(8):1109-13. PubMed ID: 15049099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term persistence in protection and response to a hepatitis B vaccine booster among adolescents immunized in infancy in the western region of China.
    Wang ZZ; Gao YH; Lu W; Jin CD; Zeng Y; Yan L; Ding F; Li T; Liu XE; Zhuang H
    Hum Vaccin Immunother; 2017 Apr; 13(4):909-915. PubMed ID: 27874311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Durability of antibody response against hepatitis B virus in healthcare workers vaccinated as adults.
    Gara N; Abdalla A; Rivera E; Zhao X; Werner JM; Liang TJ; Hoofnagle JH; Rehermann B; Ghany MG
    Clin Infect Dis; 2015 Feb; 60(4):505-13. PubMed ID: 25389254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Persistence of protection to hepatitis B vaccine and response to booster dose among children and adolescents in Dakahleya- Egypt.
    Salama II; Sami SM; Salama SI; Foud WA; Abdel Hamid AT; Said ZN
    Egypt J Immunol; 2014; 21(1):13-26. PubMed ID: 25204041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Seroprevalence of Hepatitis-B infection amongst Taiwanese university students 18 years following the commencement of a national Hepatitis-B vaccination program.
    Su FH; Chen JD; Cheng SH; Lin CH; Liu YH; Chu FY
    J Med Virol; 2007 Feb; 79(2):138-43. PubMed ID: 17177303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis B seroepidemiology and booster vaccination in pre-clinical medical students in a Malaysian university.
    Othman SN; Zainol Rashid Z; Abdul Wahab A; Abdul Samat MN; Ding CH; Ali UK
    Malays J Pathol; 2018 Dec; 40(3):295-302. PubMed ID: 30580360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of booster vaccination of hepatitis B vaccine on anti-HBV surface antigen negative children 11-15 years after primary vaccination.
    Yao J; Ren J; Shen L; Chen Y; Liang X; Cui F; Li Q; Jiang Z; Wang F
    Hum Vaccin; 2011 Oct; 7(10):1055-9. PubMed ID: 21989290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis B immune memory in children primed with hexavalent vaccines and given monovalent booster vaccines: an open-label, randomised, controlled, multicentre study.
    Zanetti AR; Romanò L; Giambi C; Pavan A; Carnelli V; Baitelli G; Malchiodi G; Valerio E; Barale A; Marchisio MA; Montù D; Tozzi AE; D'Ancona F;
    Lancet Infect Dis; 2010 Nov; 10(11):755-61. PubMed ID: 20884297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.